News Roche haemophilia data piles pressure on Shire Hemlibra threatens to take market share from Advate
News Takeda to cut IT, marketing and sales jobs after Shire merge... Takeda aiming for $1.4bn savings per year
News Takeda takes biggest gamble of 2018 with Shire merger Takeda and Shire have agreed on the remaining terms of their £46 billion merger, creating one of the largest pharma companies in the world.
News Takeda woos Shire shareholders with increased bid Fourth and probably final bid has increased cash component
News Allergan says not interested in buying Shire Allergan has said it is not interested in buying Shire after all, after announcing yesterday that it was considering a bid for the UK-listed firm also targeted by Takeda.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.